Contenidos
Asuntos regulatorios
Azithromycin ............................................................................... 4
Cilostazol-containing medicines .......................................................... 4
Denosumab .................................................................................. 4
Lapatinib ditosylate ........................................................................5
Proton pump inhibitors.....................................................................5
Strontium ranelate ..........................................................................6
Tetrazepam-containing medicines ........................................................6
Thalidomide ..................................................................................7
Tolvaptan ......................................................................................7
Valproate sodium, divalproex sodium, valproic acid ................................... 8
Seguridad de medicamentos
Ado-trastuzumab emtansine ................................................................ 9
Aqueous cream ............................................................................... 9
Bevacizumab .................................................................................. 9
Botulinum toxin type B .......................................................................10
Domperidone-containing medicines ....................................................... 10
Ezogabine ..................................................................................... 10
Flupirtine-containing medicines ............................................................ 11
Insulin degludec ............................................................................... 11
Montelukast .................................................................................... 12
Nicotinic acid, acipimox and xantinol nicotinate ......................................... 12
Nilotinib ........................................................................................ 12
Ado-trastuzumab emtansine ................................................................ 9
Aqueous cream ............................................................................... 9
Bevacizumab .................................................................................. 9
Botulinum toxin type B .......................................................................10
Domperidone-containing medicines ....................................................... 10
Ezogabine ..................................................................................... 10
Flupirtine-containing medicines ............................................................ 11
Insulin degludec ............................................................................... 11
Montelukast .................................................................................... 12
Nicotinic acid, acipimox and xantinol nicotinate ......................................... 12
Nilotinib ........................................................................................ 12
Signal
Fluoxetine and Deafness ......................................................................... 14
disponible en
http://bit.ly/1av3oKU
Fluoxetine and Deafness ......................................................................... 14
disponible en
http://bit.ly/1av3oKU
